Product Program year 2025 Source: CMS Open Payments

Zurzuvae

Drug Neurology

NDC 64406-029-01

Open in the dashboard

General payments

$2,150,131

28,426 payments

Research payments

$0

0 payments

Through program year 2025, $2,150,131 in general payments and $0 in research payments were reported against Zurzuvae (Neurology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

3 rows
Year Kind Amount Payments
2025 General $1,620,521 23,322
2024 General $491,935 5,082
2023 General $37,675 22

Breakdown

Who paid General payments · program years 2023–2025
  1. Biogen, Inc. $2,150,131 28,426 payments
Top recipients General payments · program year 2025
  1. Lethenia Baker Obstetrics & Gynecology · Thomaston, GA $77,773 5% · 97 payments
  2. Earl Peeper Obstetrics & Gynecology · New Orleans, LA $73,628 5% · 65 payments
  3. Bassem Maximos Obstetrics & Gynecology · League City, TX $64,162 4% · 64 payments
  4. Elizabeth Johnson Nurse Practitioner, Family · Evansville, IN $63,203 4% · 128 payments
  5. Deborah Knudson Gonzalez Psychiatry · Tampa, FL $62,113 4% · 66 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Obstetrics & Gynecology $672,900 42% · 3,731 practitioners
  2. Psychiatry Psychiatry & Neurology $320,267 20% · 243 practitioners
  3. Nurse Practitioner, Psychiatric/Mental Health Nurse Practitioner $175,398 11% · 727 practitioners
  4. Nurse Practitioner, Family Nurse Practitioner $146,759 9% · 936 practitioners
  5. Advanced Practice Midwife $69,242 4% · 918 practitioners

The top 5 of 84 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Florida $233,970 14% · 675 recipients
  2. California $167,616 10% · 730 recipients
  3. Texas $144,866 9% · 1,021 recipients
  4. Indiana $132,401 8% · 594 recipients
  5. Georgia $120,621 7% · 588 recipients

The top 5 of 53 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

28,426 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record